GURUFOCUS.COM » STOCK LIST » Financial Services » Insurance » China Reinsurance (Group) Corp (HKSE:01508) » Definitions » Research & Development

China Reinsurance (Group) (HKSE:01508) Research & Development : HK$0 Mil (TTM As of Dec. 2023)


View and export this data going back to 2015. Start your Free Trial

What is China Reinsurance (Group) Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. China Reinsurance (Group)'s Research & Development for the six months ended in Dec. 2023 was HK$0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0 Mil.


China Reinsurance (Group) Research & Development Historical Data

The historical data trend for China Reinsurance (Group)'s Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Reinsurance (Group) Research & Development Chart

China Reinsurance (Group) Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

China Reinsurance (Group) Semi-Annual Data
Dec13 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

China Reinsurance (Group) Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


China Reinsurance (Group)  (HKSE:01508) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


China Reinsurance (Group) Research & Development Related Terms

Thank you for viewing the detailed overview of China Reinsurance (Group)'s Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


China Reinsurance (Group) (HKSE:01508) Business Description

Traded in Other Exchanges
Address
No 11, Jinrong Avenue, Xicheng District, Beijing, CHN, 100033
China Reinsurance (Group) Corp is a Chinese company that is engaged in the reinsurance business. It provides various products and services including reinsurance, direct insurance, asset management, insurance brokerage, and insurance media service. The company offers a variety of reinsurance products for various property and casualty insurance, such as motor, property, agricultural, liability insurance, life, health, accident insurance, and asset management services. It operates through the following business segments: Property and casualty reinsurance, Life and health reinsurance, Primary property and casualty insurance, Asset Management, and Others.
Executives
Citigroup Inc. 2502 Approved lending agent
Wellington Management Group Llp 2102 Investment manager

China Reinsurance (Group) (HKSE:01508) Headlines

No Headlines